NF-κB/Rel: Agonist and antagonist roles in HIV-1 latency

Current Opinion in HIV and AIDS

Volumn 6, Issue 1, 2011, Pages 12-18

  Chan, Jonathan K L ^a   Greene, Warner C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Drug free remission; HIV 1 latency; Homeostatic proliferation; NF B; Viral eradication

Indexed keywords

HISTONE DEACETYLASE INHIBITOR; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHORBOL ESTER; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; PROSTRATIN; PROTEIN BCL 2; PROTEIN BCL XL; RNA POLYMERASE II; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR RELA; TRICHOSTATIN A; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VALPROIC ACID;

APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL SURVIVAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MEMORY T LYMPHOCYTE; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; VIRUS LATENCY; HOST PATHOGEN INTERACTION; METABOLISM; PHYSIOLOGY; REVIEW;

HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; NF-KAPPA B; TRANSCRIPTION FACTOR RELA; VIRUS LATENCY;

EID: 79954438684     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e32834124fd     Document Type: Article

References (47)

1. + central memory T cells. J Exp Med 2007; 204:79-91. (Pubitemid 46148759)
2. Chomont N, El-Far M, Ancuta P, et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 2009; 15:893-900.
3. North TW, Higgins J, Deere JD, et al. Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS. J Virol 2010; 84:2913-2922.
4. Chun TW, Nickle DC, Justement JS, et al. Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. J Infect Dis 2008; 197:714-720. (Pubitemid 351364472)
5. Carter CC, Onafuwa-Nuga A, McNamara LA, et al. HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs. Nat Med 2010; 16:446-451.
6. + T cells reveals a novel source of residual viremia in patients on antiretroviral therapy. J Virol 2009; 83:8470-8481.
7. + T cells within the gut lamina propria requires OX40 and CD30 signals. J Immunol 2009; 183:5079-5084.
8. Williams SA, Chen LF, Kwon H, et al. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J 2006; 25:139-149. (Pubitemid 43077303)
9. Stroud JC, Oltman A, Han A, et al. Structural basis of HIV-1 activation by NFkappaB: a higher-order complex of p50:RelA bound to the HIV-1 LTR. J Mol Biol 2009; 393:98-112.
10. + cells is due to epigenetic transcriptional silencing and P-TEFb restriction. J Virol 2010; 84:6425-6437.
11. Reuse S, Calao M, Kabeya K, et al. Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection. PLoS One 2009; 4:e6093.
12. Williams SA, Chen LF, Kwon H, et al. Prostratin antagonizes HIV latency by activating NFkappaB. J Biol Chem 2004; 279:42008-42017. (Pubitemid 39313652)
13. Yang HC, Xing S, Shan L, et al. Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation. J Clin Invest 2009; 119:3473-3486.
14. Williams SA, Kwon H, Chen LF, Greene WC. Sustained induction of NFkappa B is required for efficient expression of latent human immunodeficiency virus type 1. J Virol 2007; 81:6043-6056. (Pubitemid 46847040)
15. Barboric M, Nissen RM, Kanazawa S, et al. NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol Cell 2001; 8:327-337. (Pubitemid 32831550)
16. Huang B, Yang XD, Zhou MM, et al. Brd4 coactivates transcriptional activation of NFkappaB via specific binding to acetylated RelA. Mol Cell Biol 2009; 29:1375-1387.
17. Duverger A, Jones J, May J, et al. Determinants of the establishment of human immunodeficiency virus type 1 latency. J Virol 2009; 83:3078-3093.
18. Ea CK, Baltimore D. Regulation of NF-kappaB activity through lysine monomethylation of p65. Proc Natl Acad Sci USA 2009; 106:18972-18977.
19. Yang XD, Huang B, Li M, et al. Negative regulation of NF-kappaB action by Set9-mediated lysine methylation of the RelA subunit. EMBO J 2009; 28:1055-1066.
20. Knights CD, Catania J, Di Giovanni S, et al. Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate. J Cell Biol 2006; 173:533-544. (Pubitemid 43765200)
21. Burnett JC, Lim KI, Calafi A, et al. Combinatorial latency reactivation for HIV-1 subtypes and variants. J Virol 2010; 84:5958-5974.
22. Burnett JC, Miller-Jensen K, Shah PS, et al. Control of stochastic gene expression by host factors at the HIV promoter. PLoS Pathog 2009; 5: e1000260.
23. Kauder SE, Bosque A, Lindqvist A, et al. Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Pathog 2009; 5:e1000495.
24. Lenasi T, Contreras X, Peterlin BM. Transcriptional interference antagonizes proviral gene expression to promote HIV latency. Cell Host Microbe 2008; 4:123-133.
25. Han Y, Lin YB, An W, et al. Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough. Cell Host Microbe 2008; 4:134-146.
26. + T cells. PLoS Pathog 2006; 2:e68.
27. + T lymphocytes. Nat Med 2007; 13:1241-1247. (Pubitemid 47530631)
28. Jordan A, Bisgrove D, Verdin E. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J 2003; 22:1868-1877. (Pubitemid 36460143)
29. + T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes. J Virol 2004; 78:6122-6133. (Pubitemid 38715910)
30. + T cells infected in culture. AIDS 2009; 23:1461-1471.
31. Jiang G, Espeseth A, Hazuda DJ, Margolis DM. c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter. J Virol 2007; 81:10914-10923. (Pubitemid 47536066)
32. Coull JJ, Romerio F, Sun JM, et al. The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1. J Virol 2000; 74:6790-6799. (Pubitemid 30470662)
33. Blazkova J, Trejbalova K, Gondois-Rey F, et al. CpG methylation controls reactivation of HIV from latency. PLoS Pathog 2009; 5:e1000554.
34. + T cells. Blood 2009; 113:58-65.
35. Bates DL, Barthel KK, Wu Y, et al. Crystal structure of NFAT bound to the HIV-1 LTR tandem kappaB enhancer element. Structure 2008; 16:684-694. (Pubitemid 351615017)
36. Giffin MJ, Stroud JC, Bates DL, et al. Structure of NFAT1 bound as a dimer to the HIV-1 LTR kappa B element. Nat Struct Biol 2003; 10:800-806. (Pubitemid 37187650)
37. Urban MB, Baeuerle PA. The 65-kD subunit of NF-kappa B is a receptor for I kappa B and a modulator of DNA-binding specificity. Genes Dev 1990; 4:1975-1984. (Pubitemid 120012598)
38. Trushin SA, Pennington KN, Carmona EM, et al. Protein kinase Calpha (PKCalpha) acts upstream of PKCtheta to activate IkappaB kinase and NF-kappaB in T lymphocytes. Mol Cell Biol 2003; 23:7068-7081. (Pubitemid 37214672)
39. Trushin SA, Pennington KN, Algeciras-Schimnich A, Paya CV. Protein kinase C and calcineurin synergize to activate IkappaB kinase and NF-kappaB in T lymphocytes. J Biol Chem 1999; 274:22923-22931.
40. + influx. Functional synergy between Raf and calcineurin. J Immunol 1996; 157:5277-5283. (Pubitemid 126448944)
41. + signaling. Genes Dev 2008; 22:1356-1368. (Pubitemid 351717526)
42. Stellbrink HJ, van Lunzen J, Westby M, et al. Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial). AIDS 2002; 16:1479-1487. (Pubitemid 34804212)
43. Prins JM, Jurriaans S, van Praag RM, et al. Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy. AIDS 1999; 13:2405-2410.
44. Archin NM, Cheema M, Parker D, et al. Antiretroviral intensification and valproic acid lack sustained effect on residual HIV-1 viremia or resting CD4+ cell infection. PLoS One 2010; 5:e9390.
45. Chen L, Fischle W, Verdin E, Greene WC. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 2001; 293:1653-1657. (Pubitemid 32807844)
46. Chen LF, Mu Y, Greene WC. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J 2002; 21:6539-6548. (Pubitemid 35448431)
47. Yang HC, Shen L, Siliciano RF, Pomerantz JL. Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation. Proc Natl Acad Sci U S A 2009; 106:6321-6326.